CDKN2B and chronic myelogenous leukemia, BCR-ABL1 positive: Increased DNMT expression and subsequent hypermethylation of the cyclin-dependent kinase inhibitor p15INK4B have been associated with acute myeloid leukemia (AML) and the acute phase of chronic myeloid leukemia (CML) (67).